Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial

Weller Michael, Butowski Nicholas, Tran David D., Recht Lawrence D., Lim Michael, Hirte Hal, Ashby Lynn, Mechtler László, Goldlust Samuel A., Iwamoto Fabio, Drappatz Jan, O’Rourke Donald M., Wong Mark, Hamilton Mark G., Hideghéty Katalin (kollab. közrem.): Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial.
LANCET ONCOLOGY, 18 (10). pp. 1373-1385. ISSN 1470-2045 (2017)

Actions (login required)